Fundraising FoxPamir Ventures — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
Revalia Bio uses AI to convert donated human organs and tissues into multi-modal biological datasets and decision-ready insights for drug and device development.
AI & Machine LearningBiotechHealthtechNew Haven, US
Greg Tietjen(Co-Founder & Chief Executive Officer)inJenna DiRito(Co-Founder)inKourosh Saeb-Parsy(Co-Founder)inHelen Hughes(Co-Founder & Chief People Officer)Peter Buniak(Co-Founder & Advisor)inJaneta Nikolovski(Chief Data and Innovation Officer)
Co-investorsAmerica's Frontier FundBoxOne VenturesConnecticut InnovationsDniproSierra VenturesEntrepreneur First
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.